11
10
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71029 |
RCC-36 HCl
|
||
Rcc 36 is an active metabolite of temiverine that has inhibitory actions toward the atropine-resistant part of contractions, which may be related to the calcium antagonistic actions of these compounds. | |||
T26046 |
Razoxane
|
Topoisomerase | DNA Damage/DNA Repair |
Razoxane 是拓扑异构酶 II 的有效抑制剂,具有抗血管生成的作用,在肾细胞癌中具有研究价值。 | |||
T6683 |
STF-62247
STF 62247 |
Estrogen/progestogen Receptor; Autophagy | Autophagy; Endocrinology/Hormones |
STF-62247 是一种自噬诱导剂,在 RCC4 和 RCC4/VHL 细胞中的IC50分别为 0.625 μM 和 16 μM。它对 VHL 缺陷型肾细胞癌有选择性的细胞毒性。 | |||
T9698 |
UC2288
|
Mdm2; p53 | Apoptosis |
UC2288 是新型的、细胞通透性、口服有效的p21衰减试剂,基于索拉非尼的结构合成。在不依赖 于p53的情况下,它可以下调 p21 mRNA 的表达,降低 p21 蛋白水平,对 p21 蛋白的稳定性影响很小。它对VEGFR2 和 Raf 激酶没有抑制作用,即使在 10 μM。 | |||
T71027 |
KDI-792 hydrochloride
|
||
KDI-792 hydrochloride is a thromboxane dual blocker. | |||
T60904 |
ERCC1-XPF-IN-2
|
Others | Others |
ERCC1-XPF-IN-2 在核苷酸切除修复、顺铂增强和 γH2AX 测定中具有活性。ERCC1-XPF-IN-2 是 ERCC1-XPF 核酸内切酶的有效抑制剂,IC50值为 0.6 μM。 | |||
T41227 |
ARCC 4 negative control
|
||
ARCC 4 negative control is a negative control for ARCC 4. Binds androgen receptors (AR) without inducing degradation. | |||
T14318 |
ARCC-4
|
Others | Others |
ARCC-4 is an enzalutamide-based von Hippel-Lindau (VHL)-recruiting AR PROTAC and outperforms enzalutamide and it is a low-nanomolar androgen receptor (AR) degrader based on PROTAC, with a DC50 of 5 nM. ARCC-4 effectively degrades clinically relevant AR mutants associated with antiandrogen therapy[1]. | |||
T63464 | ERCC1-XPF-IN-1 | ||
ERCC1-XPF-IN-1 是有效的、高亲和力的 ERCC1-XPF 抑制剂 (IC50: 0.49 μM)。ERCC1-XPF-IN-1 能够抑制 CPDs 的去除,降低环磷酰胺对结直肠癌细胞的毒性,提高了 UV 辐射的细胞毒性作用,阻碍 DNA 修复。 | |||
T63505 |
Tivozanib hydrochloride hydrate
AV-951 hydrochloride hydrate,KRN951 hydrochloride hydrate |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Tivozanib hydrochloride hydrate (AV-951 hydrochloride hydrate) 是一种具有口服活性、选择性和高效性的血管内皮生长因子受体 (VEGFR) 酪氨酸激酶抑制剂,抑制 VEGFR-1、VEGFR-2、VEGFR-3 ,可用于研究转移性肾细胞癌 (RCC)和乳腺癌等实体肿瘤疾病。 | |||
T76723 | Tilvestamab | ||
Tilvestamab (BGB149) 是一种人源化抗AXL 抗体,阻断AXL 介导的细胞信号传导。Tilvestamab 在体外能显著抑制Gas6刺激诱导的AXL 激活,并抑制 786-0-Luc RCC 细胞中下游AXL 的磷酸化。Tilvestamab 可用于癌症,尤其是AXL 过度表达肾细胞癌的研究。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00283 |
Carbonic Anhydrase 9 Protein, Human, Recombinant (Avi & His), Biotinylated
G250,P54/58N,Carbonic Anhydrase IX,CA9,Carbonate dehydratase... |
Human | HEK293 Cells |
Carbonic anhydrases IX (CA IX), also known as membrane antigen MN or CA9, is a member of the carbonic anhydrase (CA) family and may be involved in cell proliferation and cellular transformation. CAs are zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide (H2O + CO2 = H+ + HCO3–) and thus participate in a variety of biological and physical processes. CA9 is a transmembrane enzyme expressed primarily in carcinoma cells. It is one of the best markers for hypoxia and for RCC... | |||
TMPK-00283 |
CA9/Carbonic Anhydrase IX Protein, Human, Recombinant (His & Avi)
RCC,EC 4.2.1.1,CA9,P54/58N,MN,CA-IX,CAIX,G250,PMW1 |
Human | HEK293 Cells |
CA9 is a member of the carbonic anhydrases' family, that is often expressed in cancer cells under hypoxic condition. CA9 expression potentially contributes to the regulation of cancer cell differentiation and mediates tumour-associated genes and signalling pathways, including apoptosis, hypoxia, G2M checkpoint, PI3K/AKR/mTOR signalling and TGF-beta signalling pathways. CA9/Carbonic Anhydrase IX Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The... | |||
TMPK-00524 |
CA9/Carbonic Anhydrase IX Protein, Cynomolgus, Recombinant (His)
CAIX,CA9,P54/58N,RCC,G250,EC 4.2.1.1,PMW1,CA-IX,MN |
Cynomolgus | HEK293 Cells |
CA9 is a member of the carbonic anhydrases' family, that is often expressed in cancer cells under hypoxic condition. CA9 expression potentially contributes to the regulation of cancer cell differentiation and mediates tumour-associated genes and signalling pathways, including apoptosis, hypoxia, G2M checkpoint, PI3K/AKR/mTOR signalling and TGF-beta signalling pathways. CA9/Carbonic Anhydrase IX Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The pred... | |||
TMPK-00478 |
Carbonic Anhydrase 12 Protein, Cynomolgus, Recombinant (His)
CA12,CAXII,Carbonic anhydrase,CA-XII,Tumor antigen HOM-R... |
Cynomolgus | HEK293 Cells |
Carbonic anhydrases (CAs) are a family of enzymes involved in the pH regulation of metabolically active cells/tissues. Carbonic anhydrase XII (CA XII) is a key mediator of several signaling pathways that are involved in cancer development. | |||
TMPH-02159 |
SMARCC1 Protein, Human, Recombinant (His & SUMO)
|
Human | E. coli |
SMARCC1 Protein, Human, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 41.5 kDa and the accession number is Q92922. | |||
TMPH-01380 |
ERCC3 Protein, Human, Recombinant (GST)
|
Human | E. coli |
ERCC3 Protein, Human, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 115.6 kDa and the accession number is P19447. | |||
TMPH-02314 |
XRCC5 Protein, Human, Recombinant (His & MBP)
|
Human | Baculovirus Insect Cells |
Single-stranded DNA-dependent ATP-dependent helicase that plays a key role in DNA non-homologous end joining (NHEJ) by recruiting DNA-PK to DNA. Required for double-strand break repair and V(D)J recombination. Also has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. During NHEJ, the XRCC5-XRRC6 dimer performs the recognition step: it recognizes and bind... | |||
TMPH-02315 |
XRCC5 Protein, Human, Recombinant (His & Myc)
|
Human | E. coli |
Single-stranded DNA-dependent ATP-dependent helicase that plays a key role in DNA non-homologous end joining (NHEJ) by recruiting DNA-PK to DNA. Required for double-strand break repair and V(D)J recombination. Also has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. During NHEJ, the XRCC5-XRRC6 dimer performs the recognition step: it recognizes and bind... | |||
TMPH-01621 |
BRCC3 Protein, Human, Recombinant (His & SUMO)
BRCC36,CXorf53,C6.1A,BRCC3,BRCA1/BRCA2-con... |
Human | E. coli |
Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Does not have activity toward 'Lys-48'-linked polyubiquitin chains. Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). In the BRCA1-A complex, it specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX, anta... | |||
TMPY-01763 |
Cadherin 16/CDH16 Protein, Human, Recombinant (His)
UNQ695/PRO1340,cadherin 16 |
Human | HEK293 Cells |
KSP-Cadherin/Cadherin-16 is a member of the cadherin superfamily, calcium-dependent, membrane-associated glycoproteins. The protein consists of an extracellular domain containing 6 cadherin domains, a transmembrane region and a truncated cytoplasmic domain but lacks the prosequence and tripeptide HAV adhesion recognition sequence typical of most classical cadherins. Expression is exclusively in kidney, where the protein functions as the principal mediator of homotypic cellular recognition, playi... |